Girard Partners’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
$928K Hold
8,552
0.09% 141
2024
Q1
$1.13M Hold
8,552
0.11% 136
2023
Q4
$1.04M Sell
8,552
-106
-1% -$11.8K 0.11% 147
2023
Q3
$972K Hold
8,658
0.11% 138
2023
Q2
$1.26M Hold
8,658
0.13% 128
2023
Q1
$1.12M Hold
8,658
0.12% 131
2022
Q4
$1.1M Buy
8,658
+208
+2% +$24.1K 0.13% 144
2022
Q3
$883K Hold
8,450
0.12% 136
2022
Q2
$887K Buy
+8,450
New +$1M 0.11% 131
2018
Q4
Sell
-898
Closed -$114K 844
2018
Q3
$114K Buy
+898
New +$107K 0.02% 307

Other funds holding ZBH

Girard Partners's ZBH Position: Q2 2024 in Review

Girard Partners held its Zimmer Biomet (ZBH) position steady in Q2 2024 at 8,552 shares worth $928K. The position accounts for 0.09% of the portfolio, ranked #141.

Girard Partners first reported a position in ZBH in Q3 2018 and has held it in 10 quarters since. The position peaked at $1.26M in Q2 2023. 1,005 funds tracked by Wall St. Rank hold ZBH as of Q2 2024.

  • Girard Partners held 8,552 shares of Zimmer Biomet worth $928K as of Q2 2024.
  • Girard Partners left its Zimmer Biomet share count unchanged in Q2 2024.
  • Zimmer Biomet made up 0.09% of Girard Partners's portfolio in Q2 2024, its #141 holding.
  • Girard Partners first reported a position in Zimmer Biomet in Q3 2018 and has held it in 10 quarters since.
  • Girard Partners's Zimmer Biomet position peaked at $1.26M in Q2 2023.
  • 1,005 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2024.

Based on Girard Partners's 13F filing for Q2 2024, filed 12 Aug 2024.